Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
614 | 3161 | 30.5 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
82 | 26468 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MULTIDRUG RESISTANT TUBERCULOSIS | Author keyword | 121 | 51% | 5% | 169 |
2 | MDR TB | Author keyword | 103 | 45% | 5% | 170 |
3 | DRUG SUSCEPTIBILITY TESTING | Author keyword | 67 | 64% | 2% | 65 |
4 | INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | Journal | 64 | 12% | 15% | 487 |
5 | EXTENSIVELY DRUG RESISTANT TUBERCULOSIS | Author keyword | 49 | 64% | 2% | 48 |
6 | XDR TB | Author keyword | 41 | 53% | 2% | 54 |
7 | MYCOBACTERIOL UNIT | Address | 28 | 30% | 2% | 79 |
8 | PNCA | Author keyword | 28 | 81% | 1% | 17 |
9 | NITRATE REDUCTASE ASSAY | Author keyword | 27 | 78% | 1% | 18 |
10 | SECOND LINE DRUGS | Author keyword | 25 | 70% | 1% | 21 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MULTIDRUG RESISTANT TUBERCULOSIS | 121 | 51% | 5% | 169 | Search MULTIDRUG+RESISTANT+TUBERCULOSIS | Search MULTIDRUG+RESISTANT+TUBERCULOSIS |
2 | MDR TB | 103 | 45% | 5% | 170 | Search MDR+TB | Search MDR+TB |
3 | DRUG SUSCEPTIBILITY TESTING | 67 | 64% | 2% | 65 | Search DRUG+SUSCEPTIBILITY+TESTING | Search DRUG+SUSCEPTIBILITY+TESTING |
4 | EXTENSIVELY DRUG RESISTANT TUBERCULOSIS | 49 | 64% | 2% | 48 | Search EXTENSIVELY+DRUG+RESISTANT+TUBERCULOSIS | Search EXTENSIVELY+DRUG+RESISTANT+TUBERCULOSIS |
5 | XDR TB | 41 | 53% | 2% | 54 | Search XDR+TB | Search XDR+TB |
6 | PNCA | 28 | 81% | 1% | 17 | Search PNCA | Search PNCA |
7 | NITRATE REDUCTASE ASSAY | 27 | 78% | 1% | 18 | Search NITRATE+REDUCTASE+ASSAY | Search NITRATE+REDUCTASE+ASSAY |
8 | SECOND LINE DRUGS | 25 | 70% | 1% | 21 | Search SECOND+LINE+DRUGS | Search SECOND+LINE+DRUGS |
9 | DOTS PLUS | 23 | 79% | 0% | 15 | Search DOTS+PLUS | Search DOTS+PLUS |
10 | DRUG RESISTANT TUBERCULOSIS | 23 | 49% | 1% | 35 | Search DRUG+RESISTANT+TUBERCULOSIS | Search DRUG+RESISTANT+TUBERCULOSIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RPOB MUTATIONS | 146 | 71% | 4% | 117 |
2 | PNCA MUTATIONS | 134 | 93% | 2% | 51 |
3 | MDR TB | 118 | 63% | 4% | 118 |
4 | ISONIAZID RESISTANCE | 111 | 49% | 5% | 163 |
5 | ETHAMBUTOL RESISTANCE | 88 | 82% | 2% | 51 |
6 | RIFAMPIN RESISTANCE | 80 | 42% | 5% | 144 |
7 | KATG GENE | 74 | 84% | 1% | 41 |
8 | KATG | 71 | 46% | 4% | 114 |
9 | RIFAMPICIN RESISTANCE | 67 | 46% | 3% | 110 |
10 | CATALASE PEROXIDASE GENE | 63 | 49% | 3% | 95 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 64 | 12% | 15% | 487 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis | 2009 | 203 | 47 | 85% |
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis | 2014 | 26 | 149 | 55% |
Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis | 2010 | 108 | 30 | 80% |
Mechanisms of drug resistance in Mycobacterium tuberculosis | 2009 | 155 | 106 | 72% |
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis | 2014 | 12 | 52 | 81% |
Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review | 2012 | 46 | 62 | 82% |
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system | 2012 | 40 | 51 | 90% |
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review | 2015 | 1 | 31 | 81% |
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET | 2009 | 72 | 15 | 100% |
Association between HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta-Analysis | 2014 | 8 | 27 | 81% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MYCOBACTERIOL UNIT | 28 | 30% | 2.5% | 79 |
2 | WHO ABORATING TB LUNG DIS | 16 | 54% | 0.7% | 21 |
3 | MICROBIOL MORPHOL | 15 | 88% | 0.2% | 7 |
4 | TB REFERENCE | 15 | 26% | 1.5% | 48 |
5 | MYCOBACTERIOL | 13 | 20% | 1.9% | 59 |
6 | STOP TB | 11 | 20% | 1.6% | 50 |
7 | TOMSK PENITENTIARY SERV | 11 | 100% | 0.2% | 6 |
8 | TB ELIMINAT | 10 | 13% | 2.3% | 73 |
9 | REFERENCE MYCOBACTERIA | 10 | 27% | 1.0% | 31 |
10 | ZHEJIANG PREVENT TREATMENT TB | 8 | 100% | 0.2% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192640 | SPOLIGOTYPING//IS6110 RFLP//UNITE TB MYCOBACTERIES |
2 | 0.0000168321 | EARLY BACTERICIDAL ACTIVITY//DELAMANID//BEDAQUILINE |
3 | 0.0000137575 | SMEAR MICROSCOPY//SMEAR NEGATIVE//XPERT MTB RIF |
4 | 0.0000112496 | INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//DOTS//STOP TB |
5 | 0.0000087369 | SANIDAD SEGURIDAD SOCIAL LLEIDA//UNIDAD INVEST TB BARCELONA//DENVER METRO TB CONTROL PROGRAM |
6 | 0.0000087107 | ISONIAZID PREVENTIVE THERAPY//TB CONTROL PROGRAMME//TB HIV |
7 | 0.0000086202 | CAS 58001 44 8//HOSPITAL PATHOGENS//RV3676 |
8 | 0.0000081670 | CHILDHOOD TUBERCULOSIS//DESMOND TUTU TB//TUBERCULOSIS IN CHILDREN |
9 | 0.0000081003 | DIABETE SUCRE//COHORT REPORTS//FIELD HLTH PROGRAMME |
10 | 0.0000080993 | OCCUPATIONAL TUBERCULOSIS//NOSOCOMIAL TUBERCULOSIS//TUBERCULOSIS RISK |